Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease

被引：22
作者：
Assouan, Deborah [1 ]
Lebon, Delphine [1 ]
Charbonnier, Amandine [1 ]
Royer, Bruno [1 ]
Marolleau, Jean-Pierre [1 ]
Gruson, Berengere [1 ]
机构：
[1] Ctr Hosp Univ Amiens, Hematol, Amiens, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷 / 05期
关键词：
graft-versus-host disease; hematopoietic stem cell transplantation; ruxolitinib; malignant haematology; corticosteroids; TRANSPLANTATION;
D O I：
10.1111/bjh.14679
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：687 / 689
页数：3
相关论文
共 50 条
  • [31] Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis
    Fan, Shuang
    Huo, Wen-Xuan
    Yang, Yang
    Shen, Meng-Zhu
    Mo, Xiao-Dong
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness
    Mohty, Mohamad
    Holler, Ernst
    Jagasia, Madan
    Jenq, Robert
    Malard, Florent
    Martin, Paul
    Socie, Gerard
    Zeiser, Robert
    [J]. BLOOD, 2020, 136 (17) : 1903 - 1906
  • [33] Graft-versus-host disease
    Sauer, M.
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2007, 155 (11) : 1021 - +
  • [34] Concomitant Ruxolitinib and Ibrutinib for Graft-Versus-Host Disease (GVHD): The First Reported Use in Pediatric Patients
    Gagliardi, Thomas A.
    Milner, Jordan
    Cairo, Mitchell S.
    Steinberg, Amir
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [35] The Effectiveness of Ruxolitinib for Acute/Chronic Graft-versus-Host Disease in Children: A Retrospective Study
    Yang, Wenli
    Zhu, Guanghua
    Qin, Maoquan
    Li, Zhigang
    Wang, Bin
    Yang, Jun
    Wang, Tianyou
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 743 - 752
  • [36] Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease
    Gozzo, Lucia
    Leotta, Salvatore
    Romano, Giovanni Luca
    Vetro, Calogero
    Duminuco, Andrea
    Milone, Giuseppe
    Cupri, Alessandra
    Palumbo, Fanny Erika
    Brancati, Serena
    Ruscica, Rosy
    Longo, Laura
    Vitale, Daniela Cristina
    Fiorenza, Giorgia
    Lombardo, Giovanni Enrico
    Lazzara, Antonio
    Di Raimondo, Francesco
    Palumbo, Giuseppe Alberto
    Drago, Filippo
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [37] Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease
    Cazeau, Naomi
    Rodriguez, Stephany L.
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (04) : 397 - 403
  • [38] Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease
    Algeri, Mattia
    Becilli, Marco
    Locatelli, Franco
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (11) : 1299 - 1313
  • [39] Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease
    Melgarejo-Ortuno, Alejandra
    Escudero-Vilaplana, Vicente
    Luis Revuelta, Jose
    Bailen, Rebeca
    Collado-Borrell, Roberto
    Gomez-Centurion, Ignacio
    Oarbeascoa, Guillen
    Kwon, Mi
    Heranz, Ana
    Luis Diez-Martin, Jose
    Sanjurjo, Maria
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 751 - 755
  • [40] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    Willenbacher, W
    Basara, N
    Blau, IW
    Fauser, AA
    Kiehl, MG
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823
12345